• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

他汀类药物与骨骼健康:一篇综述短文

STATINS AND BONE HEALTH: A MINI REVIEW.

作者信息

Morse Leslie R, Coker Jennifer, Battaglino Ricardo A

机构信息

Rocky Mountain Regional Spinal Injury System, Craig Rehabilitation Hospital, Englewood, Colorado, United States of America.

Department of Physical Medicine and Rehabilitation, University of Colorado School of Medicine, Aurora, Colorado, United States of America.

出版信息

Actual osteol. 2018 Jan-Apr;14(1):31-35.

PMID:30237809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6143288/
Abstract

Statins are a widely prescribed class of medications that inhibit similar pathways as the anti-resorptive bisphosphonate drugs. Statins target the mevalonate pathway by blocking HMG-CoA reductase. Several recent meta-analyses concluded statins are osteoprotective in the general population. Here we present current literature exploring the mechanisms underlying the putative osteoprotective effects of statins. We also review recent clinical studies, ranging from observational cohort studies to randomized clinical trials, testing the effect of statins on bone health in various populations.

摘要

他汀类药物是一类广泛应用的处方药,其作用途径与抗吸收双膦酸盐药物相似。他汀类药物通过阻断HMG-CoA还原酶来靶向甲羟戊酸途径。最近的几项荟萃分析得出结论,他汀类药物对普通人群具有骨保护作用。在此,我们展示了探索他汀类药物假定骨保护作用潜在机制的当前文献。我们还回顾了最近的临床研究,从观察性队列研究到随机临床试验,这些研究测试了他汀类药物对不同人群骨骼健康的影响。

相似文献

1
STATINS AND BONE HEALTH: A MINI REVIEW.他汀类药物与骨骼健康:一篇综述短文
Actual osteol. 2018 Jan-Apr;14(1):31-35.
2
The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity.他汀类药物抑制骨吸收的能力与其对HMG-CoA还原酶活性的抑制作用直接相关。
J Bone Miner Res. 2003 Jan;18(1):88-96. doi: 10.1359/jbmr.2003.18.1.88.
3
HMG CoA reductase inhibitors and the skeleton: a comprehensive review.HMG CoA还原酶抑制剂与骨骼:全面综述
Osteoporos Int. 2003 Jun;14(4):273-82. doi: 10.1007/s00198-002-1323-x. Epub 2003 May 8.
4
Statins, fracture risk, and bone remodeling.他汀类药物、骨折风险和骨重塑。
J Endocrinol Invest. 2009;32(4 Suppl):32-7.
5
Effects of statins on bone mineral density: a meta-analysis of clinical studies.他汀类药物对骨密度的影响:临床研究的荟萃分析。
Bone. 2007 Jun;40(6):1581-7. doi: 10.1016/j.bone.2007.02.019. Epub 2007 Mar 1.
6
Statins inhibit blastocyst formation by preventing geranylgeranylation.他汀类药物通过阻止香叶基香叶基化来抑制胚泡形成。
Mol Hum Reprod. 2016 May;22(5):350-63. doi: 10.1093/molehr/gaw011. Epub 2016 Feb 7.
7
Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.HMG-CoA还原酶抑制剂的药效学与药代动力学。异同点。
Clin Pharmacokinet. 1997 May;32(5):403-25. doi: 10.2165/00003088-199732050-00005.
8
Statins: under investigation for increasing bone mineral density and augmenting fracture healing.他汀类药物:正在研究其对增加骨密度和促进骨折愈合的作用。
Expert Opin Investig Drugs. 2008 Oct;17(10):1435-63. doi: 10.1517/13543784.17.10.1435.
9
Exploring the association between statins use or HMG-CoA reductase inhibition and migraine: a systematic review and meta-analysis.探索他汀类药物使用或HMG-CoA还原酶抑制与偏头痛之间的关联:一项系统评价和荟萃分析。
J Headache Pain. 2025 Feb 3;26(1):23. doi: 10.1186/s10194-025-01957-w.
10
Prevention of Hepatocellular Carcinoma by Statins: Clinical Evidence and Plausible Mechanisms.他汀类药物预防肝细胞癌:临床证据和可能的机制。
Semin Liver Dis. 2019 May;39(2):141-152. doi: 10.1055/s-0039-1679956. Epub 2019 Mar 25.

引用本文的文献

1
Statin use and longitudinal bone marrow lesion burden: analysis of knees without osteoarthritis from the Osteoarthritis Initiative study.他汀类药物的使用与纵向骨髓病变负担:来自骨关节炎倡议研究的无骨关节炎膝关节分析。
Skeletal Radiol. 2025 Jan 31. doi: 10.1007/s00256-025-04878-6.
2
β-Caryophyllene and Statins in Bone Fracture Healing - A Narrative Review.β-石竹烯与他汀类药物在骨折愈合中的作用——一篇叙述性综述
Orthop Res Rev. 2025 Jan 23;17:31-42. doi: 10.2147/ORR.S506427. eCollection 2025.
3
Statins in the Cause and Prevention of Cancer: Confounding by Indication and Mediation by Rhabdomyolysis and Phosphate Toxicity.他汀类药物在癌症病因及预防中的作用:指征性混杂以及横纹肌溶解和磷酸盐毒性介导作用
J Cardiovasc Dev Dis. 2024 Sep 23;11(9):296. doi: 10.3390/jcdd11090296.
4
Simvastatin Significantly Reduced Alcohol-Induced Cardiac Damage in Adolescent Mice.辛伐他汀可显著减轻未成年酒精诱导的心脏损伤。
Cardiovasc Toxicol. 2024 Jan;24(1):15-26. doi: 10.1007/s12012-023-09821-6. Epub 2024 Jan 23.
5
Effect of Diclofenac and Simvastatin on Bone Defect Healing-An In Vivo Animal Study.双氯芬酸和辛伐他汀对骨缺损愈合的影响——一项体内动物研究
Biomimetics (Basel). 2022 Sep 25;7(4):143. doi: 10.3390/biomimetics7040143.
6
Regulation of Osteoclast Differentiation and Activity by Lipid Metabolism.脂质代谢调控破骨细胞分化和活性
Cells. 2021 Jan 7;10(1):89. doi: 10.3390/cells10010089.
7
Crosstalk of Brain and Bone-Clinical Observations and Their Molecular Bases.脑与骨的对话——临床观察及其分子基础。
Int J Mol Sci. 2020 Jul 13;21(14):4946. doi: 10.3390/ijms21144946.

本文引用的文献

1
Wheelchair use and lipophilic statin medications may influence bone loss in chronic spinal cord injury: findings from the FRASCI-bone loss study.轮椅使用和亲脂性他汀类药物可能会影响慢性脊髓损伤患者的骨质流失:FRASCI-骨质流失研究的结果
Osteoporos Int. 2016 Dec;27(12):3503-3511. doi: 10.1007/s00198-016-3678-4. Epub 2016 Jul 13.
2
The Evaluation of Therapeutic Efficacy and Safety Profile of Simvastatin Prodrug Micelles in a Closed Fracture Mouse Model.辛伐他汀前药胶束在闭合性骨折小鼠模型中的治疗效果及安全性评估
Pharm Res. 2016 Aug;33(8):1959-71. doi: 10.1007/s11095-016-1932-2. Epub 2016 May 10.
3
Simvastatin prodrug micelles target fracture and improve healing.辛伐他汀前药胶束靶向骨折部位并促进愈合。
J Control Release. 2015 Feb 28;200:23-34. doi: 10.1016/j.jconrel.2014.12.028. Epub 2014 Dec 24.
4
Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy.鞘氨醇-1-磷酸信号转导的激活作为他汀类药物治疗多效作用的潜在潜在机制。
Crit Rev Clin Lab Sci. 2013 May-Jun;50(3):79-89. doi: 10.3109/10408363.2013.813013.
5
HMG-CoA reductase inhibitors (statins) and bone mineral density: a meta-analysis.HMG-CoA 还原酶抑制剂(他汀类药物)与骨密度:一项荟萃分析。
Bone. 2013 May;54(1):151-6. doi: 10.1016/j.bone.2013.01.044. Epub 2013 Feb 4.
6
Mechanisms of bone anabolism regulated by statins.他汀类药物调节骨合成代谢的机制。
Biosci Rep. 2012 Dec;32(6):511-9. doi: 10.1042/BSR20110118.
7
Lifestyle factors, medications, and disease influence bone mineral density in older men: findings from the CHAMP study.生活方式因素、药物和疾病会影响老年男性的骨密度:来自 CHAMP 研究的结果。
Osteoporos Int. 2011 Sep;22(9):2421-37. doi: 10.1007/s00198-010-1478-9. Epub 2010 Nov 26.
8
The cornucopia of "pleiotropic" actions of statins: myogenesis as a new mechanism for statin-induced benefits?他汀类药物“多效性”作用的丰富内涵:肌生成是他汀类药物产生益处的新机制?
Circ Res. 2009 Jan 30;104(2):144-6. doi: 10.1161/CIRCRESAHA.108.192500.
9
Transdermal lovastatin enhances fracture repair in rats.经皮给予洛伐他汀可促进大鼠骨折修复。
J Bone Miner Res. 2008 Nov;23(11):1722-30. doi: 10.1359/jbmr.080603.
10
Locally applied Simvastatin improves fracture healing in mice.局部应用辛伐他汀可促进小鼠骨折愈合。
BMC Musculoskelet Disord. 2007 Sep 27;8:98. doi: 10.1186/1471-2474-8-98.